Scientists studying lupus or rheumatoid arthritis can obtain information on the individual cells of patients taking part in Phase 1 clinical trials,…
Ines Martins, PhD
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ines Martins, PhD
DxTerity Diagnostics researchers are seeking ways to develop an at-home blood test to monitor individual disease activity in lupus patients.
A video storytelling campaign and contest, called #IAmInvisibleNoMore, intended to raise awareness of “invisible” disabilities — which can range…
Canada’s Aurinia Pharmaceuticals has launched ALL IN, an educational program to raise awareness of lupus nephritis. The disease, which…
Exagen Diagnostics is collaborating with GlaxoSmithKline (GSK) to bring greater awareness of its laboratory tests, meant to facilitate early diagnosis…
The Invisible Disabilities Association has made a video to promote public understanding of invisible diseases like lupus and help those…
The Lupus Foundation of America recently reviewed the notable achievements and overall advances realized in 2017, finding that significant progress…
The Lupus Multi-Cultural Engagement Partnership (Lupus MCEP) was recently launched at an inaugural meeting in New York City to address…
The Oklahoma Medical Research Foundation (OMRF) recently launched the world’s first lupus prevention study, known as the SMILE clinical trial.
The University of Alabama at Birmingham (UAB) has received a one-year, $250,000 grant from the Lupus Research Alliance…